Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 8.01, 9.01 · 8-K

Baxter International Inc.

BAXNYSEEQUITYCurrent

Other Events

Item 8.01 Other Events. On August 4, 2026, Baxter International Inc. (the “Company”) issued a press release announcing the commencement of cash tender offers (each, an “Offer” and together, the “Offers”) to purchase up to $500 million in aggregate purchase price (excluding accrued and unpaid interest) of one or more series of the Company’s outstanding 3.132% Senior Notes due 2051, 3.500% Senior No…

Filed Aug 4, 2026Accepted Aug 4, 2026, 8:32 AM EDTCIK 10456Accession 0001628280-26-052180
Share

Press release in this filing

BAXTER ANNOUNCES CASH TENDER OFFERS →

Company context

At Baxter, we are everywhere healthcare happens - and everywhere it is going, with essential solutions in the hospital, physician's office and other sites of care. For nearly a century, our customers have counted on us as a vital and trusted partner. And every day, millions of patients and healthcare providers rely on our unmatched portfolio of connected solutions, medical devices, and advanced injectable technologies. Approximately 37,500 Baxter team members live our enduring Mission: to Save and Sustain Lives. Together, we are redefining how care is delivered to make a greater impact today, tomorrow, and beyond. To learn more, visit www.baxter.com and follow us on X, LinkedIn and Facebook.

Current securities

Recent company filings

  1. 10-Q filingOct 29, 2026
  2. Results of Operations and Financial Condition · Other EventsOct 29, 2026
  3. 4 filingSep 3, 2026
  4. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureAug 19, 2026
  5. Entry into a Material Definitive Agreement · Other EventsAug 18, 2026

Registered securities in this filing

Baxter International Inc. · 8-K · Filed 2026-08-04

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, $1.00 par value

Symbol
BAX (NYSE)
Exchange
Not supplied
Classification
COMMON
Filing context

Context: c-2

Dimensions: us-gaap:StatementClassOfStockAxis

Common Stock, $1.00 par value

Symbol
BAX (NYSE)
Exchange
NYSE
Classification
COMMON
Filing context

Context: c-3

Dimensions: us-gaap:StatementClassOfStockAxis

1.3% Global Notes due 2029

Symbol
BAX 29
Exchange
NYSE
Classification
DEBT
Filing context

Context: c-4

Dimensions: us-gaap:StatementClassOfStockAxis

Accession 000162828026052180 · 3 registered-security cover members

Read the exact SEC filing ↗

Disclosure sections

Items 8.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events. On August 4, 2026, Baxter International Inc. (the “Company”) issued a press release announcing the commencement of cash tender offers (each, an “Offer” and together, the “Offers”) to purchase up to $500 million in aggregate purchase price (excluding accrued and unpaid interest) of one or more series of the Company’s outstanding 3.132% Senior Notes due 2051, 3.500% Senior Notes due 2046, 4.500% Senior Notes due 2043 and 2.539% Senior Notes due 2032 (together, the “Notes”), upon the terms and subject to the conditions set forth in the Company’s offer to purchase (as discussed below). A copy of the press release announcing the Offers is attached as Exhibit 99.1 to this Current Report on Form 8-K and is hereby incorporated by reference herein. This Current Report on Form 8-K, including the press release incorporated by reference, is neither an offer to sell nor a solicitation of offers to buy any Notes. The Offers are being made only pursuant to the offer to purchase of the Company, dated August 4, 2026. The Offers are not being made to holders of Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction.

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.